Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes.
Metzemaekers M, Mortier A, Vacchini A, Boff D, Yu K, Janssens R, Farina FM, Milanesi S, Berghmans N, Pörtner N, Van Damme J, Allegretti M, Teixeira MM, Locati M, Borroni EM, Amaral FA, Proost P.
Metzemaekers M, et al. Among authors: van damme j.
Sci Signal. 2021 Mar 9;14(673):eaax3053. doi: 10.1126/scisignal.aax3053.
Sci Signal. 2021.
PMID: 33688078